Genome-wide association studies (GWAS) of adiposity

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Adiposity is strongly heritable and one of the leading risk factors for type 2 diabetes, cardiovascular disease, cancer, and premature death. In the past 8 years, genome-wide association studies (GWAS) have greatly increased our understanding of the genes and biological pathways that regulate adiposity by identifying more than 100 novel susceptibility loci for overall adiposity and more than 70 loci for body fat distribution. The results for overall adiposity highlight a significant neuronal component, whereas loci regulating body fat distribution demonstrate a central role for adipocyte biology and insulin resistance in the pathophysiology. The effect sizes of all identified loci are small, and even in aggregate, they explain <3 % of the variance in each adiposity trait. This and other evidence suggest that numerous new loci will be identified in extended meta-analyses in the future. The translation of the new discoveries into clinical care remains a major challenge. As the first step, further studies are required to establish the causal genes and variants and to disentangle the exact physiological mechanisms underlying each genotype-phenotype association.

Cite

CITATION STYLE

APA

Ingelsson, E., & Kilpeläinen, T. O. (2016). Genome-wide association studies (GWAS) of adiposity. In The Genetics of Type 2 Diabetes and Related Traits: Biology, Physiology and Translation (pp. 91–109). Springer International Publishing. https://doi.org/10.1007/978-3-319-01574-3_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free